Literature DB >> 32321655

An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients.

Jing-Zhang Wang1, Rui-Ying Zhang2, Jing Bai2.   

Abstract

Entities:  

Keywords:  Antioxidant; Antiviral immunity; COVID-19; Cardiac injury; Reactive oxygen species

Mesh:

Substances:

Year:  2020        PMID: 32321655      PMCID: PMC7133895          DOI: 10.1016/j.ijcard.2020.04.009

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
To the Editor, The 2019 novel coronavirus (2019-nCoV, COVID-19) has spread in nearly 100 countries, infected 217,645 patients, and resulted in 8942 deaths worldwide. The major clinical feature is Respiratory Distress Syndrome and one key complication is Acute Cardiac Injury [1]. Interestingly, a recent article of IJC may provide a clue to heart protection for COVID-19-infected individuals, based on the oxidative stress theory [2]. According to recent clinical reports, the therapeutic time for COVID-19 infection is much longer than 14 days, but long-time viral stimulation is prone to suddenly elicit intensive immunological reactions, cytokine storm and immune-cell infiltration in vivo; however, some immunocytes especially macrophages and neutrophils can produce numerous reactive oxygen species (ROS) including H2O2, (·O2 −), (·OH), etc. [[2], [3], [4]]. Generally, a certain level of ROS is important for regulating immunological responses and for clearing viruses, but excessive ROS will oxidize cellular proteins and membrane lipids and quickly destroy not only virus-infected cells but also normal cells in lung and even heart, resulting in multiple organ failure. Thus, a potential anti-oxidative therapy could be proposed to alleviate cardiogenic casualties caused by COVID-19. Inexpensive medicinal antioxidants include Vitamin C (ascorbic acid) and Vitamin E, because their reductive hydrogen atoms can react with ROS and then produce nontoxic water [5]. Plant-derived molecules (similar to ancient Chinese medicine), such as Curcumin and Baicalin, may have potential anti-oxidative efficacy, too. Predictably, a proper dose of antioxidants may ameliorate cardiac injuries of critically ill COVID-19-infected patients (but possibly not including mild-symptom patients).

Statement of authorship

The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.

Declaration of competing interest

None.
  26 in total

Review 1.  Familiar dermatologic drugs as therapies for COVID-19.

Authors:  M Ortega-Peña; R González-Cuevas
Journal:  Actas Dermosifiliogr       Date:  2020-12-23

2.  Perspective on the treatment of non-small cell lung cancer in the context of potential SARS-CoV-2 infection during the pandemic.

Authors:  George Theodoropoulos; Katerina Albanis; Medhi Wangpaichitr
Journal:  J Curr Sci Technol       Date:  2021-01

3.  Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19).

Authors:  Marvin R McCreary; Patrick M Schnell; Dale A Rhoda
Journal:  Sci Rep       Date:  2022-06-29       Impact factor: 4.996

4.  Mechanisms of Bioactivities of Fucoidan from the Brown Seaweed Fucus vesiculosus L. of the Barents Sea.

Authors:  Olga N Pozharitskaya; Ekaterina D Obluchinskaya; Alexander N Shikov
Journal:  Mar Drugs       Date:  2020-05-22       Impact factor: 5.118

5.  Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients.

Authors:  Kholoud F Aliter; Rami A Al-Horani
Journal:  Curr Pharm Des       Date:  2021       Impact factor: 3.116

Review 6.  Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes.

Authors:  Aikaterini Kountouri; Emmanouil Korakas; Ignatios Ikonomidis; Athanasios Raptis; Nikolaos Tentolouris; George Dimitriadis; Vaia Lambadiari
Journal:  Antioxidants (Basel)       Date:  2021-05-09

Review 7.  Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates.

Authors:  Sajad Fakhri; Zeinab Nouri; Seyed Zachariah Moradi; Esra Küpeli Akkol; Sana Piri; Eduardo Sobarzo-Sánchez; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  Molecules       Date:  2021-05-14       Impact factor: 4.411

Review 8.  Potential Impact of Diabetes and Obesity on Alveolar Type 2 (AT2)-Lipofibroblast (LIF) Interactions After COVID-19 Infection.

Authors:  Marjan Nouri-Keshtkar; Sara Taghizadeh; Aisan Farhadi; Aysan Ezaddoustdar; Samira Vesali; Roya Hosseini; Mehdi Totonchi; Azam Kouhkan; Chengshui Chen; Jin-San Zhang; Saverio Bellusci; Yaser Tahamtani
Journal:  Front Cell Dev Biol       Date:  2021-07-08

Review 9.  Unraveling the mystery of Covid-19 cytokine storm: From skin to organ systems.

Authors:  Suruchi Garg; Mandeep Garg; Nidhi Prabhakar; Pankaj Malhotra; Ritesh Agarwal
Journal:  Dermatol Ther       Date:  2020-07-07       Impact factor: 3.858

Review 10.  A Rapid Advice Guideline for the Prevention of Novel Coronavirus Through Nutritional Intervention.

Authors:  Savita Budhwar; Kashika Sethi; Manali Chakraborty
Journal:  Curr Nutr Rep       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.